Xiong Yun Yun, Mok Vincent
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, Shatin 999077, Hong Kong.
J Aging Res. 2011;2011:617927. doi: 10.4061/2011/617927. Epub 2011 Aug 23.
Age-related white matter changes (WMC) are considered manifestation of arteriolosclerotic small vessel disease and are related to age and vascular risk factors. Most recent studies have shown that WMC are associated with a host of poor outcomes, including cognitive impairment, dementia, urinary incontinence, gait disturbances, depression, and increased risk of stroke and death. Although the clinical relevance of WMC has been extensively studied, to date, only very few clinical trials have evaluated potential symptomatic or preventive treatments for WMC. In this paper, we reviewed the current understanding in the pathophysiology, epidemiology, clinical importance, chemical biomarkers, and treatments of age-related WMC.
年龄相关性白质改变(WMC)被认为是小动脉硬化性小血管疾病的表现,与年龄和血管危险因素相关。最近的研究表明,WMC与一系列不良后果有关,包括认知障碍、痴呆、尿失禁、步态障碍、抑郁以及中风和死亡风险增加。尽管WMC的临床相关性已得到广泛研究,但迄今为止,仅有极少数临床试验评估了针对WMC的潜在对症或预防性治疗方法。在本文中,我们综述了目前对年龄相关性WMC的病理生理学、流行病学、临床重要性、化学生物标志物及治疗方法的认识。